Desq Long
Sign in

Company

Definium Therapeutics, Inc.

DFTX · CIK 0001813814

SEC FORM 4
$38,574.72

Definium Therapeutics, Inc. (DFTX)

Acquisition (code M) of 1,086 shares at $35.52 per share.

Reporting Person Vallone Carol A · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001193125-26-395892 · filed 2026-09-18 · View filing →

SEC FORM 4
$57,862.08

Definium Therapeutics, Inc. (DFTX)

Acquisition (code M) of 1,629 shares at $35.52 per share.

Reporting Person Krebs Andreas · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001193125-26-395893 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 750,000 shares at $0.00 per share.

Reporting Person Barrow Robert · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 14, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-389887 · filed 2026-09-14 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 125,000 shares at $0.00 per share.

Reporting Person Roberts Brandi · Officer Title Chief Financial Officer · Transaction Code A

Traded Sep 14, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-389888 · filed 2026-09-14 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 125,000 shares at $0.00 per share.

Reporting Person Sullivan Mark · Officer Title Chief Legal Officer · Transaction Code A

Traded Sep 14, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-389889 · filed 2026-09-14 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 125,000 shares at $0.00 per share.

Reporting Person Wiley Matthew T. · Officer Title Chief Commercial Officer · Transaction Code A

Traded Sep 14, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-389890 · filed 2026-09-14 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 200,000 shares at $0.00 per share.

Reporting Person Karlin Daniel · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 14, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-389892 · filed 2026-09-14 · View filing →

SEC FORM 4
$721,732.62

Definium Therapeutics, Inc. (DFTX)

Sale of 19,023 shares at $37.94 per share.

Reporting Person Barrow Robert · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-384042 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 40,000 shares at $0.00 per share.

Reporting Person Barrow Robert · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-384042 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 62,500 shares at $0.00 per share.

Reporting Person Roberts Brandi · Officer Title Chief Financial Officer · Transaction Code A

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-345835 · filed 2026-08-12 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 62,500 shares at $0.00 per share.

Reporting Person Wiley Matthew T. · Officer Title Chief Commercial Officer · Transaction Code A

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-345836 · filed 2026-08-12 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 62,500 shares at $0.00 per share.

Reporting Person Sullivan Mark · Officer Title Chief Legal Officer · Transaction Code A

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-345837 · filed 2026-08-12 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 100,000 shares at $0.00 per share.

Reporting Person Karlin Daniel · Officer Title Chief Medical Officer · Transaction Code A

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-345838 · filed 2026-08-12 · View filing →

SEC FORM 4
$0.00

Definium Therapeutics, Inc. (DFTX)

Acquisition (code A) of 375,000 shares at $0.00 per share.

Reporting Person Barrow Robert · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-345839 · filed 2026-08-12 · View filing →